Company Filing History:
2 out of 108 
1 out of 1,115 
Years Active: 2018-2025
Title: Yeon Joon Park: Innovator in Medical Diagnostics
Introduction
Yeon Joon Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the detection of antibiotic-resistant bacteria. With a total of 3 patents, his work is paving the way for advancements in healthcare.
Latest Patents
One of his latest patents is a probe for detecting carbapenem-resistant bacteria. This innovative compound, represented by Chemical Formula 1, is designed to identify antibiotic-resistant bacteria with high sensitivity. The probe includes a carbapenem structure, a linker, and a fluorophore, making it suitable for various biochemical research applications. It can clinically detect carbapenemase-producing antibiotic-resistant bacteria, facilitating molecular diagnosis of infectious diseases. This technology is particularly valuable for in-vitro diagnostics.
Another notable patent is the medical test slide unit. This unit features a frame main body with a marker part that has multiple position indicating markers. It is designed to hold a slide for specimens to be examined under a microscope, enhancing the efficiency of medical testing.
Career Highlights
Yeon Joon Park has worked with esteemed institutions such as the Catholic University of Korea Industry-Academic Cooperation Foundation and the Industry-University Cooperation Foundation at Hanyang University. His experience in these organizations has contributed to his innovative research and development in medical technology.
Collaborations
Throughout his career, Yeon Joon Park has collaborated with notable colleagues, including Kang Gyun Park and Sun Joon Min. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yeon Joon Park's contributions to medical diagnostics through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the detection and treatment of antibiotic-resistant bacteria, showcasing the importance of innovation in healthcare.